Training new scientists to improve cancer treatment
Career Enhancement Program
['FUNDING_OTHER'] · UNIVERSITY OF MICHIGAN AT ANN ARBOR · NIH-10917052
The Career Enhancement Program at the University of Michigan is helping new scientists learn how to turn their lab discoveries into real treatments for cancer, so they can work together with doctors to find better ways to help patients.
Quick facts
| Phase | ['FUNDING_OTHER'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | UNIVERSITY OF MICHIGAN AT ANN ARBOR (nih funded) |
| Locations | 1 site (ANN ARBOR, UNITED STATES) |
| Trial ID | NIH-10917052 on ClinicalTrials.gov |
What this research studies
The Career Enhancement Program at the University of Michigan focuses on developing early career scientists who are dedicated to advancing cancer treatment through molecularly targeted radiosensitization. This program aims to mentor a diverse group of investigators, helping them transition from basic research to clinical applications that can directly benefit cancer patients. By fostering collaboration between basic scientists and clinicians, the program seeks to enhance the translation of laboratory discoveries into effective treatments. Participants will engage in pre-clinical testing and clinical trials to explore innovative approaches to cancer care.
Who could benefit from this research
Good fit: Ideal candidates for participation or benefit from this research include early career scientists and established researchers interested in cancer biology and treatment.
Not a fit: Patients who are not involved in research or do not have a background in scientific investigation may not receive direct benefits from this program.
Why it matters
Potential benefit: If successful, this research could lead to improved cancer treatment strategies that enhance the effectiveness of radiation therapy.
How similar studies have performed: Other research initiatives focused on training scientists in translational cancer research have shown promise in improving patient outcomes.
Where this research is happening
ANN ARBOR, UNITED STATES
- UNIVERSITY OF MICHIGAN AT ANN ARBOR — ANN ARBOR, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: LJUNGMAN, MATS — UNIVERSITY OF MICHIGAN AT ANN ARBOR
- Study coordinator: LJUNGMAN, MATS
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions: Cancer Biology, Cancer Patient